Vaccine-maker Bharat Biotech claimed that with several hundred million doses administered worldwide, Covaxin has demonstrated an excellent safety record with minimal adverse events and no vaccine associated cases detected for myocarditis or thrombocytopenia
India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready.
The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbidities will get the vaccine on priority.
The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase. The final plan is likely to be ready by end October-November, the report said.
Climate activist Sonam Wangchuk, held under the National Security Act (NSA) in Jodhpur jail, remains a symbol of hope and…
Rare birds, butterflies, mammals, and reptiles thrive in one of Bengaluru’s richest grasslands. The grassland soaks monsoon runoff, recharges groundwater,…
Fossil fuels still power much of the world, even though renewable energy has become cheaper in most places and avoids…
In a bold critique on October 16, Congress leader Rahul Gandhi accused Prime Minister Narendra Modi of being "frightened" of…
In June 2023, the Centre submitted before the Supreme Court of India that gay marriages are an ‘urban, elitist’ concept.…
In Himachal Pradesh’s Kibber village, a team of local women were a key part of the scientific monitoring effort to…
This website uses cookies.